Affiliation:
1. Department of Clinical Oncology, Fondazione Poliambulanza, 25124 Brescia, Italy
2. Department of Anatomical Pathology, Fondazione Poliambulanza, 25124 Brescia, Italy
Abstract
In recent years, precision medicine has taken an increasing place in various branches of medical oncology, including colorectal cancer. Among the potentially relevant mutations for this cancer is the KRAS mutation, initially defined as “untargetable”; today, we see the birth of new molecules that target one of the variants of the KRAS mutation, KRAS G12C, having a significant impact on the therapeutic options for other malignancies, such as metastatic lung cancer. This fundamental step forward has stimulated scientific research on other potential targets of KRAS, both indirect and direct, and combination treatments aiming to overcome the mechanisms of resistance to these drugs that decrease in efficacy in colorectal cancer. What was once a negative predictive marker of response to anti-EGFR drugs today has become a potential target for targeted treatments. In turn, the prognostic role of the mutation has become extremely interesting, making it a potentially useful element in therapeutic decision-making, not only regarding oncological treatments but also in a more complex and complete manner within a global vision of the patient, involving other figures on the multidisciplinary team, such as surgeons, radiotherapists, and interventional radiologists.
Subject
Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics
Reference89 articles.
1. Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., and Przybyłowicz, K.E. (2021). A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers, 13.
2. The Adenoma-carcinoma Sequence in Colorectal Neoplasia;Gibbons;Surg. Oncol. Clin. N. Am.,1996
3. COSMIC: Mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer;Forbes;Nucleic Acids Res.,2010
4. Isoform-specific ras functions in development and cancer;Quinlan;Futur. Oncol.,2009
5. A Comprehensive Survey of Ras Mutations in Cancer;Prior;Cancer Res.,2012